Ensys Biosciences宣布行使220万美元总收益的认购权

2025-04-24 05:13

Ensysce Biosciences (NASDAQ:ENSC) has entered a definitive agreements for the immediate exercise of certain outstanding warrants for gross proceeds of around $2.2M.
ENSC -21.52% after hours to $2.88.
The company will purchase up to an aggregate of 630,376 shares of common stock of the company originally issued in March 2025, having an exercise price of $3.24 per share.
In consideration for the immediate exercise of the warrants for cash and the payment of additional $0.125 per new unregistered warrant, the company will issue new unregistered warrants to purchase shares of common stock.
The new warrants will be exercisable for an aggregate of up to 1.26M shares of common stock, at an exercise price of $1.90 per share and will be immediately exercisable upon issuance. 630,376 of the new warrants will have a term of eighteen months from the issuance date, and 630,376 of the new warrants will have a term of five years from the issuance date.
The offering is expected to close on or about April 24, 2025.
Source: Press Release

More on Ensysce Biosciences